From Checked Locks to Silent Rituals Inside the Mind of OCD

ISLAMABAD (GNP): Obsessive compulsive disorder (OCD) affects between one and three percent of people worldwide, according to health data reviewed by Harvard Medical School’s health publishing division and a clinical overview archived by the National Center for Biotechnology Information (NCBI), with mental health professionals continuing to stress that early diagnosis substantially improves long-term outcomes for patients.

The condition is marked by two core features: obsessions, which are intrusive and distressing thoughts that repeatedly intrude on a person’s mind, and compulsions, repetitive behaviors or mental acts performed to ease the anxiety those thoughts create.

Clinicians note that common obsessions include fears of contamination, worries about causing harm through negligence, intrusive violent or sexual thoughts, and a need for symmetry or order. Compulsions associated with these fears range from repeated handwashing and lock-checking to counting, arranging objects, and silently repeating words or phrases.

According to the NCBI review, a diagnosis under the DSM-5 TR criteria requires that these obsessions or compulsions consume at least one hour a day and cause significant distress or impairment in social or occupational functioning. Most adult patients retain insight into their condition and recognize that their fears are irrational, though a small percentage, roughly two to four percent, do not, a factor that clinicians say makes the disorder harder to treat.

Research cited in both sources points to a mixed biological and environmental origin. Twin studies have estimated the heritability of OCD at close to 48 percent, a figure that drops to around 35 percent once prenatal factors are accounted for.

Neuroimaging research has focused on the cortico-striato-thalamo-cortical loop, a brain circuit linking the prefrontal cortex to deeper structures such as the striatum and thalamus, where heightened activity has repeatedly been observed in patients with the disorder. Serotonin, dopamine and glutamate signaling have all been implicated, though researchers caution that no single neurotransmitter theory fully explains the condition.

Epidemiological data show the disorder most commonly emerges between the ages of 18 and 29, though nearly a quarter of male patients show symptoms before age 10, while onset in women tends to occur later, often during adolescence. Women are reported to be affected at roughly 1.6 times the rate of men. The peripartum and postpartum periods carry particularly elevated risk, with some new mothers experiencing distressing intrusive thoughts about harming their infants, a symptom that clinicians say is frequently underreported out of fear of stigma or judgment.

On the treatment front, both sources identify cognitive behavioral therapy, and specifically exposure and response prevention, as the most empirically supported psychological intervention, often matching or exceeding the effectiveness of medication in clinical comparisons.

Selective serotonin reuptake inhibitors remain the first-line pharmacological option, typically prescribed at higher doses than those used for depression or general anxiety, with clomipramine, a tricyclic antidepressant, used as an alternative in resistant cases. For patients who do not respond to first-line treatment, a group estimated between 25 and 40 percent, augmentation strategies involving antipsychotics or glutamatergic agents such as memantine and N-acetylcysteine have shown some benefit.

Also Read: Frontline Climate-Vulnerable Countries Face Longer Wait For Loss And Damage Funds

For the most severe and treatment-resistant cases, neuromodulation techniques are gaining ground. Deep transcranial magnetic stimulation has received United States Food and Drug Administration approval for OCD, while deep brain stimulation, a reversible and adjustable neurosurgical option, has reported response rates between 40 and 70 percent in patients who have exhausted other options. Older ablative procedures such as anterior cingulotomy and capsulotomy remain in use in select cases, with reported effectiveness rates of 41 and 54 percent respectively.

Both sources caution that OCD rarely resolves without treatment and often persists for five to ten years before a patient sees a psychiatrist. The World Health Organization lists OCD among the ten most disabling conditions globally in terms of financial and quality-of-life impact, and researchers have noted an association between the disorder and elevated suicide risk, particularly when compounded by coexisting depression or anxiety. Clinicians interviewed in the literature reiterate that while OCD is a chronic condition prone to fluctuating between remission and relapse, most patients who receive sustained treatment see meaningful improvement, and some recover fully.